BeSafe B2.0 Smart Multisensory Platform for Safety in Workplaces.

Wearable technologies are becoming a profitable means of monitoring a person's health state, such as heart rate and physical activity. The use of the smartwatch is becoming consolidated, not only as a novelty but also as a very useful tool for daily use. In addition, other devices, such as helmets or belts, are beneficial for monitoring workers and the early detection of any anomaly. They can provide valuable information, especially in work environments, where they help reduce the rate of accidents and occupational diseases, which makes them powerful Personal Protective Equipment (PPE). The constant monitoring of the worker's health can be done in real-time, through temperature, falls, noise, impacts, or heart rate meters, activating an audible and vibrating alarm when an anomaly is detected. The gathered information is transmitted to a server in charge of collecting and processing it. In the first place, this paper provides an exhaustive review of the state of the art on works related to electronics for human activity behavior. After that, a smart multisensory bracelet, combined with other devices, developed a control platform that can improve operators' security in the working environment. Artificial Intelligence and the Internet of Things (AIoT) bring together the information to improve safety on construction sites, power stations, power lines, etc. Real-time and historic data is used to monitor operators' health and a hybrid system between Gaussian Mixture Model and Human Activity Classification. That is, our contribution is also founded on the use of two machine learning models, one based on unsupervised learning and the other one supervised. Where the GMM gave us a performance of 80%, 85%, 70%, and 80% for the 4 classes classified in real time, the LSTM obtained a result under the confusion matrix of 0.769, 0.892, and 0.921 for the carrying-displacing, falls, and walking-standing activities, respectively. This information was sent in real time through the platform that has been used to analyze and process the data in an alarm system.

Transcranial direct current stimulation for the treatment of tinnitus: a review of clinical trials and mechanisms of action.

BACKGROUND: Tinnitus is the perception of sound in the absence of any external acoustic stimulation. Transcranial direct current stimulation (tDCS) has shown promising though heterogeneous therapeutic outcomes for tinnitus. The present study aims to review the recent advances in applications of tDCS for tinnitus treatment. In addition, the clinical efficacy and main mechanisms of action of tDCS on suppressing tinnitus are discussed. METHODS: The study was performed in accordance with the PRISMA guidelines. The databases of the PubMed (1980-2018), Embase (1980-2018), PsycINFO (1850-2018), CINAHL, Web of Science, BIOSIS Previews (1990-2018), Cambridge Scientific Abstracts (1990-2018), and google scholar (1980-2018) using the set search terms. The date of the most recent search was 20 May, 2018. The randomized controlled trials that have assessed at least one therapeutic outcome measured before and after tDCS intervention were included in the final analysis. RESULTS: Different tDCS protocols were used for tinnitus ranging single to repeated sessions (up to 10) consisting of daily single session of 15 to 20-min and current intensities ranging 1-2 mA. Dorsolateral prefrontal cortex (DLPFC) and auditory cortex are the main targets of stimulation. Both single and repeated sessions showed moderate to significant treatment effects on tinnitus symptoms. In addition to improvements in tinnitus symptoms, the tDCS interventions particularly bifrontal DLPFC showed beneficial outcomes on depression and anxiety comorbid with tinnitus. Heterogeneities in the type of tinnitus, tDCS devices, protocols, and site of stimulation made the systematic reviews of the literature difficult. However, the current evidence shows that tDCS can be developed as an adjunct or complementary treatment for intractable tinnitus. TDCS may be a safe and cost-effective treatment for tinnitus in the short-term application. CONCLUSIONS: The current literature shows moderate to significant therapeutic efficacy of tDCS on tinnitus symptoms. Further randomized placebo-controlled double-blind trials with large sample sizes are needed to reach a definitive conclusion on the efficacy of tDCS for tinnitus. Future studies should further focus on developing efficient disease- and patient-specific protocols.